21
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition(s):Gram Positive Bacterial InfectionsLast Updated:January 17, 2023Recruiting
Bacterial Infections: 8408 Clinical Trials, Page 3 of 841
Hide Studies Not Open or Pending
22
PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring
Condition(s):Severe Bacterial InfectionLast Updated:February 21, 2021Terminated
23
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
Condition(s):Bacterial InfectionsLast Updated:March 29, 2022Terminated
24
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
Condition(s):Suspected or Documented Gram-negative Bacterial InfectionLast Updated:December 23, 2022Recruiting
25
New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn
Condition(s):Nosocomial InfectionLast Updated:February 5, 2020Completed
26
Resistant Bacterial Infections in the Early Post LDLT Period
Condition(s):Transplantation InfectionLast Updated:February 6, 2017Completed
27
biomArkers to differeNtiate bacTerial From vIral iNfEctions
Condition(s):Infection, Bacterial; Infection ViralLast Updated:June 18, 2019Completed
28
Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
Condition(s):Bacterial InfectionsLast Updated:October 12, 2009Completed
29
Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy
Condition(s):Bacterial InfectionsLast Updated:December 9, 2022Not yet recruiting
30
Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections
Condition(s):Bacterial InfectionsLast Updated:February 28, 2020Approved for marketing